copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Homepage - GRAIL GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages
Multi-cancer early detection - GRAIL Multi-cancer early detection (MCED) testing is a new approach to screening for cancer Adding a blood-based multi-cancer early detection test can help screen for many of the deadliest cancers that don’t have recommended screening today 7,8
Press Releases - GRAIL GRAIL and University of Oxford to Present Results From First Prospective Study of Multi-Cancer Early Detection in a Symptomatic Patient Population at 2023 ASCO Annual Meeting
Clinical Studies - GRAIL We are committed to the utmost scientific rigor and have enrolled over 300,000 participants in a clinical study program to demonstrate broad applicability of our multi-cancer early detection technologies To support and validate our technology, we are partnering with leading community and academic medical centers around the world
Leadership Team - GRAIL To pursue a mission like GRAIL’s, it takes all of us—a unified collective of courageous, adaptable, and open-minded big thinkers dedicated to creating a better world
Our History - GRAIL The test detected cell-free DNA from cancer present in the mother’s blood In 2016, Illumina spun out a separate entity to focus on researching this incredible discovery, naming it GRAIL because the co-founders believed a simple blood test could be the “holy GRAIL” of cancer detection
GRAIL Announces Positive Top-Line Results From The Galleri® PATHFINDER . . . GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages
Methylation - GRAIL In 2019, GRAIL announced its proprietary methylation technology, which comprises detection of DNA shed into the blood and machine learning, to recognize a “fingerprint” for cancer
GRAIL and Quest Diagnostics Provide GRAIL’s Galleri® Multi-Cancer Early . . . GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages